Helfman, D. M., et al., “Differential Effects of Various Phosphodiesterase Inhibitors, Pyrimidine and Purine Compounds, and Inorganic Phosphates on Cyclic CMP, Cyclic AMP and Cyclic GMP Phosphodiesterases”, Biochemical Pharmacology, vol. 31, No. 1, pp. 43-47 (1982). |
Hanifin, J. M., et al., “Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic Dermatitis”, The Journal of Investigative Dermatology, vol. 104, No. 1, pp. 51-56 (1996). |
Posternak, “Cyclic AMP and the Skin”, Front. Matrix Biol., vol. 6 pp. 85-100 (1978). |
Posternak, T., “Cyclic AMP and Cyclic GMP”, Annu. Rev. Pharmacol., vol. 14, pp. 23-33 (1974). |
Robison, G. A. et al., “Cyclic AMP”, Chapter 1-5, pp. 1-145 (Academic, New York 1971). |
Goyarts, E., et al., “Correlation Between In Vitro Cyclic Adenosine Monophosphate Phosphodiesterase Inhibition and In Vivo Anti-Inflammatory Effect”, Skin Pharmacol Appl Skin Physiol, vol. 13, issue 2, pp. 86-92 (Mar., 2000). |